Latest Breaking News On - Aeromics inc - Page 1 : comparemela.com

Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema

/PRNewswire/ Simcere Pharmaceutical Group and Aeromics, Inc. today announced that Simcere dosed the first subjects in the SIM0307 (AER-271) Phase I study.

United statesHong kongRenhong tangJinsheng renWang yongjunMike gresserLauren beaneyThomas zindrickPrnewswire simcere pharmaceutical groupChina national medical products administrationAeromics incSimcere pharmaceutical groupCapital medical universityPharmaceutical groupBeijing tiantanProfessor wang yongjun

Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema

/PRNewswire/ Simcere Pharmaceutical Group and Aeromics, Inc. today announced that Simcere dosed the first subjects in the SIM0307 (AER-271) Phase I study.

United statesHong kongRenhong tangJinsheng renWang yongjunMike gresserLauren beaneyThomas zindrickPrnewswire simcere pharmaceutical groupChina national medical products administrationAeromics incSimcere pharmaceutical groupCapital medical universityPharmaceutical groupBeijing tiantanProfessor wang yongjun

NeuroTrauma Sciences Announces Expansion of Its Executive Leadership Team

NeuroTrauma Sciences Announces Expansion of Its Executive Leadership Team
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

John claude saltielDavid lawrenceCarl longSusan pietropaoloAnthony caggianoJudith hedstromConstant pharmaceuticalsAlteon incNeurotrauma sciencesAcorda therapeuticsPrnewswire neurotrauma sciencesCorporate developmentAeromics incBusiness developmentNeurotrauma sciences as viceHead of research development